World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
50
Citations
9028
World Ranking
4451
National Ranking
267

Karine Lacombe publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Karine Lacombe sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 302 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Karine Lacombe D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Karine Lacombe sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 50 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Karine Lacombe is affiliated with Hôpital Saint-Antoine in France and has an extensive publication record in the field of medicine, particularly focused on infectious diseases and epidemiology. Their research spans multiple subfields, including hepatology, neurology, and general health professions.

The scientist's work is primarily concentrated on COVID-19 and related viral infections, with a significant number of studies addressing clinical research on COVID-19, SARS-CoV-2, and long-term effects of the disease. Other major topics include hepatitis C virus research, hepatitis B virus studies, liver disease diagnosis and treatment, and HIV/AIDS research and interventions.

Frequent publication venues for their work comprise:

  • Médecine et Maladies Infectieuses Formation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • SSRN Electronic Journal
  • Journal of Hepatology

Frequent co-authors include:

  • Nadia Valin
  • Anders Boyd
  • Linda Wittkop
  • Florence Ader
  • Thibault Chiarabini

Some representative recent papers authored or co-authored by Karine Lacombe are:

  • Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia, 2020, JAMA Internal Medicine
  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial, 2021, The Lancet Infectious Diseases
  • Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19, 2020, Blood
  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial, 2021, The Lancet Respiratory Medicine
  • Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?, 2020, Vox Sanguinis

Their research contributes to understanding treatment efficacy and clinical strategies for viral infections, particularly in the context of the COVID-19 pandemic. Their work addresses therapeutic interventions such as immunomodulatory drugs and convalescent plasma therapy, which are key areas of study for hospitalized patients with varying severity of COVID-19 pneumonia.

Best Publications

  • Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure

    Mirjam B. Zeisel;Julie Lucifora;William S. Mason;Camille Sureau

  • Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.

    Florence Ader;Maude Bouscambert-Duchamp;Maya Hites;Nathan Peiffer-Smadja;Nathan Peiffer-Smadja

  • COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).

    Livio Pagano;Livio Pagano;Jon Salmanton-García;Francesco Marchesi;Alessandro Busca

  • Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19.

    Thomas Hueso;Thomas Hueso;Cécile Pouderoux;Hélène Péré;Anne Lise Beaumont

  • Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

    Pierre-Louis Tharaux;Gilles Pialoux;Arthur Pavot;Xavier Mariette

  • Campylobacter Bacteremia: Clinical Features and Factors Associated with Fatal Outcome

    Jérôme Pacanowski;Valérie Lalande;Karine Lacombe;Karine Lacombe;Cherif Boudraa

  • HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe

    Patrick Ingiliz;Thomas C Martin;Alison Rodger;Hans-Jürgen Stellbrink

  • HIV and viral hepatitis coinfections: advances and challenges

    Karine Lacombe;Juergen Rockstroh

  • Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?

    Pierre Tiberghien;Xavier de Lamballerie;Pascal Morel;Pierre Gallian

  • Reducing the neglected burden of viral hepatitis in Africa: Strategies for a global approach

    Maud Lemoine;Serge Eholié;Karine Lacombe

  • Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study

    Jurgen Rockstroh;Karine Lacombe;Rolando M Viani;Chloe Orkin

  • Major role of hepatitis B genotypes in liver fibrosis during coinfection with HIV.

    Karine Lacombe;Véronique Massari;Pierre-Marie Girard;Lawrence Serfaty

  • Prolonged in-hospital stay and higher mortality after Covid-19 among patients with non-Hodgkin lymphoma treated with B-cell depleting immunotherapy.

    Rémy Duléry;Sylvain Lamure;Marc Delord;Roberta Di Blasi

  • Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

    L Ryom;C Boesecke;M Bracchi;J Ambrosioni

  • Emerging RNA-Dependent RNA Polymerase Mutation in a Remdesivir-Treated B-cell Immunodeficient Patient With Protracted Coronavirus Disease 2019.

    Martin Martinot;Aude Jary;Samira Fafi-Kremer;Valentin Leducq

  • Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients.

    Anders Boyd;Karine Lacombe;Fabien Lavocat;Sarah Maylin

  • Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study

    Karen Champenois;Karen Champenois;Anthony Cousien;Anthony Cousien;Lise Cuzin;Stéphane Le Vu

  • Long-term hepatitis B virus dynamics in HIV-hepatitis B virus-co-infected patients treated with tenofovir disoproxil fumarate.

    Karine Lacombe;Joël Gozlan;Pierre-Yves Boelle;Lawrence Serfaty

  • Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancy and COVID-19: a longitudinal cohort and propensity score analysis

    Unknown

  • Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

    Unknown

  • Performance of rapid tests for detection of HBsAg and anti-HBsAb in a large cohort, France.

    Julie Bottero;Anders Boyd;Joel Gozlan;Maud Lemoine

  • Use of infliximab to treat psoriatic arthritis in HIV-positive patients.

    Jérémie Sellam;Béatrice Bouvard;Charles Masson;Mickael Rousière

Frequent Co-Authors

Pierre-Marie Girard
Pierre-Marie Girard Institut Pasteur
Constance Delaugerre
Constance Delaugerre Université Paris Cité
Philippe Morlat
Philippe Morlat University of Bordeaux
Fabrice Carrat
Fabrice Carrat Sorbonne University
Xavier Anglaret
Xavier Anglaret University of Bordeaux
Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University
Dominique Salmon
Dominique Salmon Université Paris Cité
Jürgen K. Rockstroh
Jürgen K. Rockstroh University Hospital Bonn
Jean-Michel Molina
Jean-Michel Molina Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in studying Microbiology in the USA, there are various related online degrees that can complement or expand their skill set. Many healthcare and science fields now offer flexible options, including shortest online medical billing and coding certificate programs, which allow graduates to enter the medical administration side of health industries quickly.

For those looking to advance their clinical knowledge, a range of what medical degrees can i get online options are available—providing flexible pathways to careers in medicine, public health, or laboratory science without the constraints of on-campus attendance.

If you're interested in public health, exploring accredited online mph programs easy to get into can offer a practical route into health policy, epidemiology, or biostatistics roles that align well with a microbiology background.

Additionally, combining microbiology with a focus on child development can lead to careers like child life specialist, which offers a rewarding professional path. Understanding a child life specialist salary with bachelor degree can help guide decisions on education investment and career expectations within this niche healthcare field.

Best Scientists Citing Karine Lacombe

Trending Scientists

Recently Published Articles